Lead discovery using molecular docking.
暂无分享,去创建一个
[1] I D Kuntz,et al. Predicting the structure of protein complexes: a step in the right direction. , 1996, Chemistry & biology.
[2] S A Benner,et al. Protein Structure Prediction , 1996, Science.
[3] G. Rishton. Reactive compounds and in vitro false positives in HTS , 1997 .
[4] I. Kuntz,et al. Molecular docking to ensembles of protein structures. , 1997, Journal of molecular biology.
[5] Mark A. Murcko,et al. Virtual screening : an overview , 1998 .
[6] M. Murcko,et al. Consensus scoring: A method for obtaining improved hit rates from docking databases of three-dimensional structures into proteins. , 1999, Journal of medicinal chemistry.
[7] P. Focia,et al. Efficient identification of inhibitors targeting the closed active site conformation of the HPRT from Trypanosoma cruzi. , 2000, Chemistry & biology.
[8] L. Kuhn,et al. Virtual screening with solvation and ligand-induced complementarity , 2000 .
[9] D. Rognan,et al. Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations. , 2000, Journal of medicinal chemistry.
[10] C. Bayly,et al. Fast, efficient generation of high-quality atomic charges. AM1-BCC model: I. Method , 2000, J. Comput. Chem..
[11] D. Kostrewa,et al. Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening. , 2000, Journal of medicinal chemistry.
[12] Araz Jakalian,et al. Fast, efficient generation of high‐quality atomic charges. AM1‐BCC model: I. Method , 2000 .
[13] J S Mason,et al. Library design and virtual screening using multiple 4-point pharmacophore fingerprints. , 1999, Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing.
[14] M. Hatada,et al. Structure-based design of an osteoclast-selective, nonpeptide src homology 2 inhibitor with in vivo antiresorptive activity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[15] E. Shakhnovich,et al. Analysis of knowledge‐based protein‐ligand potentials using a self‐consistent method , 2008, Protein science : a publication of the Protein Society.
[16] I D Kuntz,et al. Development and screening of a polyketide virtual library for drug leads against a motilide pharmacophore. , 2000, Journal of molecular graphics & modelling.
[17] A. Sali,et al. Comparative protein structure modeling of genes and genomes. , 2000, Annual review of biophysics and biomolecular structure.
[18] Tudor I. Oprea,et al. Property distribution of drug-related chemical databases* , 2000, J. Comput. Aided Mol. Des..
[19] Martin Stahl,et al. Modifications of the scoring function in FlexX for virtual screening applications , 2000 .
[20] G. Klebe,et al. Knowledge-based scoring function to predict protein-ligand interactions. , 2000, Journal of molecular biology.
[21] Robert Bywater,et al. Improving the Odds in Discriminating "Drug-like" from "Non Drug-like" Compounds , 2000, J. Chem. Inf. Comput. Sci..
[22] J A McCammon,et al. Accommodating protein flexibility in computational drug design. , 2000, Molecular pharmacology.
[23] I. Enyedy,et al. Structure-based approach for the discovery of bis-benzamidines as novel inhibitors of matriptase. , 2001, Journal of medicinal chemistry.
[24] Design of selective and soluble inhibitors of tumor necrosis factor-alpha converting enzyme (TACE). , 2001, Journal of medicinal chemistry.
[25] M. Lambert,et al. Design of Selective and Soluble Inhibitors of Tumor Necrosis Factor-α Converting Enzyme (TACE)+ , 2001 .
[26] I. Muegge,et al. Simple selection criteria for drug-like chemical matter. , 2001, Journal of medicinal chemistry.
[27] A. Ortiz,et al. Evaluation of docking functions for protein-ligand docking. , 2001, Journal of medicinal chemistry.
[28] T. Bishop,et al. Homology modeling using multiple molecular dynamics simulations and docking studies of the human androgen receptor ligand binding domain bound to testosterone and nonsteroidal ligands. , 2001, Journal of medicinal chemistry.
[29] Malin M. Young,et al. Design, docking, and evaluation of multiple libraries against multiple targets , 2001, Proteins.
[30] R D Hull,et al. Chemical similarity searches using latent semantic structural indexing (LaSSI) and comparison to TOPOSIM. , 2001, Journal of medicinal chemistry.
[31] F. Jørgensen,et al. A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities. , 2001, Journal of medicinal chemistry.
[32] G Klebe,et al. A new target for shigellosis: rational design and crystallographic studies of inhibitors of tRNA-guanine transglycosylase. , 2000, Journal of molecular biology.
[33] D. Vanderwall,et al. Inhibitors of dihydrodipicolinate reductase, a key enzyme of the diaminopimelate pathway of Mycobacterium tuberculosis. , 2001, Biochimica et biophysica acta.
[34] D. Bashford,et al. Solvation energy density occlusion approximation for evaluation of desolvation penalties in biomolecular interactions , 2001, Proteins.
[35] Yuan-Ping Pang,et al. EUDOC: a computer program for identification of drug interaction sites in macromolecules and drug leads from chemical databases , 2001, J. Comput. Chem..
[36] Ruben Abagyan,et al. In silico discovery of novel Retinoic Acid Receptor agonist structures , 2001, BMC Structural Biology.
[37] Y. Pang,et al. Discovery of a new inhibitor lead of adenovirus proteinase: steps toward selective, irreversible inhibitors of cysteine proteinases , 2001, FEBS letters.
[38] M. Mizutani,et al. Discovery of novel aldose reductase inhibitors using a protein structure-based approach: 3D-database search followed by design and synthesis. , 2001, Journal of medicinal chemistry.
[39] Ray Luo,et al. Ligand-receptor docking with the Mining Minima optimizer , 2001, J. Comput. Aided Mol. Des..
[40] I. Enyedy,et al. Discovery of small-molecule inhibitors of Bcl-2 through structure-based computer screening. , 2001, Journal of medicinal chemistry.
[41] Irwin D. Kuntz,et al. Virtual Screening of Combinatorial Libraries across a Gene Family: in Search of Inhibitors of Giardia lamblia Guanine Phosphoribosyltransferase , 2001, Antimicrobial Agents and Chemotherapy.
[42] R. García-Domenech,et al. General topological patterns of known drugs. , 2001, Journal of molecular graphics & modelling.
[43] Thomas Lengauer,et al. FlexE: efficient molecular docking considering protein structure variations. , 2001, Journal of molecular biology.
[44] Gerhard Klebe,et al. Subnanomolar Inhibitors from Computer Screening: A Model Study Using Human Carbonic Anhydrase II. , 2001, Angewandte Chemie.
[45] Shingo Makino,et al. Discovery of a novel serine protease inhibitor utilizing a structure-based and experimental selection of fragments technique , 2001, J. Comput. Aided Mol. Des..
[46] R Abagyan,et al. High-throughput docking for lead generation. , 2001, Current opinion in chemical biology.
[47] R. Stroud,et al. Predicting and harnessing protein flexibility in the design of species-specific inhibitors of thymidylate synthase. , 2001, Chemistry & biology.
[48] K. Fukasawa,et al. Structure-based generation of a new class of potent Cdk4 inhibitors: new de novo design strategy and library design. , 2001, Journal of medicinal chemistry.
[49] I. Muegge. Effect of ligand volume correction on PMF scoring , 2001, J. Comput. Chem..
[50] A. Caflisch,et al. Efficient electrostatic solvation model for protein‐fragment docking , 2001, Proteins.
[51] Jun Xu,et al. Drug-Like Index: A New Approach to Measure Drug-Like Compounds and Their Diversity. , 2001 .
[52] G Klebe,et al. Docking ligands onto binding site representations derived from proteins built by homology modelling. , 2001, Journal of molecular biology.
[53] Roberto Olender,et al. A Fast Algorithm for Searching for Molecules Containing a Pharmacophore in Very Large Virtual Combinatorial Libraries , 2001, J. Chem. Inf. Comput. Sci..
[54] M Karplus,et al. Use of MCSS to design small targeted libraries: application to picornavirus ligands. , 2001, Journal of the American Chemical Society.
[55] Wolfgang Guba,et al. Development of a virtual screening method for identification of "frequent hitters" in compound libraries. , 2002, Journal of medicinal chemistry.
[56] B. Shoichet,et al. Molecular docking and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B. , 2002, Journal of medicinal chemistry.
[57] B. Shoichet,et al. A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. , 2002, Journal of medicinal chemistry.
[58] D. Goodsell,et al. Automated docking to multiple target structures: Incorporation of protein mobility and structural water heterogeneity in AutoDock , 2002, Proteins.
[59] G. Whitesides,et al. Combinatorial computational method gives new picomolar ligands for a known enzyme , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[60] Bohdan Waszkowycz,et al. PRO_SELECT: combining structure-based drug design and array-based chemistry for rapid lead discovery. 2. The development of a series of highly potent and selective factor Xa inhibitors. , 2002, Journal of medicinal chemistry.
[61] Brian K. Shoichet,et al. Structure-Based Discovery of a Novel, Noncovalent Inhibitor of AmpC β-Lactamase , 2002 .
[62] B. Matthews,et al. A model binding site for testing scoring functions in molecular docking. , 2002, Journal of molecular biology.
[63] R. Clark,et al. Consensus scoring for ligand/protein interactions. , 2002, Journal of molecular graphics & modelling.